Academic profile
My undergraduate training in Pharmaceutic Preparations at Heilongjiang University of Chinese Medicine gave me a foundation in formulation science, modern drug-delivery systems, pharmaceutical analysis, and experimental pharmacology. Together, these subjects taught me to see drug development across design, manufacture, quality evaluation, and biological effect.
Beyond coursework, I investigated natural-product interventions for diabetes using GC–MS, enzyme-inhibition assays, network pharmacology, molecular docking, and in vivo validation. Quality-control experience at Bayer (China) and Dihon Pharmaceutical further introduced me to HPLC, near-infrared spectroscopy, microbiological testing, and GMP systems.
In the D2HP programme at Université Paris-Saclay, my training has expanded to drug development, major pathologies, pharmacy and biotechnology, and interdisciplinary pharmaceutical science. I have also extended my experimental background into clinical data analysis, using NHANES data to study the predictive performance of UHR for cardiovascular disease in cancer patients.
From April to July 2026, under the supervision of Dr. habil. Tamás Sovány at the University of Szeged, I investigated hot-melt extrusion of HPMC-based filaments for potential FDM tablet printing. Across these experiences, I am most interested in connecting formulation technology, drug delivery, experimental pharmacology, and population evidence to develop health products that are both scientifically robust and practically relevant.